Share This Page

 
Now on Twitter!

Follow us: ChinaBio

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

>> Preview...
Free White Paper

>> Download now...

SciClone Buys China Rights to Anti-Nausea Drug

publication date: Jul 28, 2009
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

SciClone Pharmaceuticals has in-licensed China rights to Ondansetron RapidFilm, a product developed by APR Applied Pharma Research SA that uses thin-film technology to deliver an established nausea drug. The rapidly dissolving product is administered to treat side effects of nausea and vomiting following surgery, chemotherapy, and radiotherapy. More details...

Stock Symbol: (NSDQ: SCLN)




Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...


Login

  

    
   
  Subscribe 
Forgot password?
>> Login help...
ChinaBio® Events

ChinaBio® Partnering Forum 2012
May 23-24, 2012
Suzhou, China

>>More events...
Partner Events

China Healthcare Investment Conference 2012
March 13-15, 2012
Shanghai, China


Shanghai CEO Conference
March 28-29, 2012
Shanghai, China

>>More details...
Other Events

China Pharmaceutical R&D Summit
April 23-26, 2012
Shanghai, China


Biosimilars Asia 2012
April 23-26, 2012
Shanghai, China


Vaccines China 2012
April 23-26, 2012
Shanghai, China

Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners